. Cerebrovascular response to decreased hematocrit: effect of cell-free hemoglobin, plasma viscosity, and CO 2. Am J Physiol Heart Circ Physiol 285: H1600-H1608, 2003. First published June 19, 2003 10.1152/ajpheart.00077.2003.-The effect of transfusing a nonextravasating, zero-link polymer of cell-free hemoglobin on pial arteriolar diameter, cerebral blood flow (CBF), and O 2 transport (CBF ϫ arterial O2 content) was compared with that of transfusing an albumin solution at equivalent reductions in hematocrit (ϳ19%) in anesthetized cats. The influence of viscosity was assessed by coinfusion of a highviscosity solution of polyvinylpyrrolidone (PVP), which increased plasma viscosity two-to threefold. Exchange transfusion of a 5% albumin solution resulted in pial arteriolar dilation, increased CBF, and unchanged O2 transport, whereas there were no significant changes over time in a control group. Exchange transfusion of a 12% polymeric hemoglobin solution resulted in pial arteriolar constriction and unchanged CBF and O2 transport. Coinfusion of PVP with albumin produced pial arteriolar dilation that was similar to that obtained with transfusion of albumin alone. In contrast, coinfusion of PVP with hemoglobin converted the constrictor response to a dilator response that prevented a decrease in CBF. Pial arteriolar dilation to hypercapnia was unimpaired in groups transfused with albumin or hemoglobin alone but was attenuated in the largest vessels in albumin and hemoglobin groups coinfused with PVP. Unexpectedly, hypocapnic vasoconstriction was blunted in all groups after transfusion of albumin or hemoglobin alone or with PVP. We conclude that 1) the increase in arteriolar diameter after albumin transfusion represents a compensatory response that prevents decreased O2 transport at reduced O2-carrying capacity, 2) the decrease in diameter associated with near-normal O2-carrying capacity after cell-free polymeric hemoglobin transfusion represents a compensatory mechanism that prevents increased O2 transport at reduced blood viscosity, 3)
CEREBRAL BLOOD FLOW (CBF) is well known to increase during anemia, and the increase is often adequate to maintain bulk oxygen transport [CBF ϫ arterial O 2 content (Ca O 2 )] (11, 28) . The increase in CBF is attributed to both reduced Ca O 2 and blood viscosity (2, 26) . The importance of each factor appears to depend on the degree of anemia and the initial state of oxygenation (2, (6) (7) (8) 24) . Changes in arteriolar diameter during anemia (6, 16, 17) imply that CBF is actively regulated rather than simply a passive effect of the decrease in viscosity. This active regulation has been referred to as viscosity autoregulation (18) .
When hematocrit was reduced by an exchange transfusion of a cell-free, tetrameric hemoglobin (Hb) solution, pial arterioles were observed to constrict, whereas dilation was observed after exchange transfusion with albumin (Alb) solutions (1) . This difference in the vascular response to decreased hematocrit may be attributed to increased oxygenation by cell-free Hb. However, transfusion of tetrameric Hb solutions produces renal and splanchnic vasoconstriction and arterial hypertension (29) , which also may induce autoregulatory pial arteriolar constriction.
It is now appreciated that transfusion of polymers of cross-linked Hb are less likely to increase arterial blood pressure than tetramers of cross-linked Hb (22, 23) , probably because of less extravasation and consequent scavenging of nitric oxide (NO) adjacent to arteriolar smooth muscle in peripheral organs. We (14) have previously described a polymerization process producing amide covalent bonds between Hb tetramers that does not require the residual presence of exogenous cross-linking agents such as glutaraldehyde or O-raffinose (14) . This polymer, designated zero-link bovine Hb polymer (ZL-HbBv), has a large molecular size (ϳ20 MDa), does not extravasate into renal lymph, and does not produce arterial hypertension. The first objective of the present study was to determine whether differences in the pial arteriolar diameter response to exchange transfusion between Alb and cell-free Hb solutions are sustained over a 2-h period after transfusion of a Hb polymer that does not increase arterial blood pressure.
Patients with increased plasma viscosity secondary to elevated immunoglobulin proteins are reported to have lower CBF than anemic patients at matched hematocrit (9) . Experimentally, however, increases in CBF during moderate anemia were not attenuated when plasma viscosity was increased by infusion of a viscous solution of polyvinylpyrrolidone (PVP; ϳ1.1 MDa) unless hematocrit was reduced to Ͻ19% (21) . A similar attenuation of CBF has been observed with high-molecular-weight dextran at a hematocrit of 16% (25) . These results imply active vasodilation to maintain O 2 transport when perturbations in plasma viscosity are imposed on the microcirculation at moderate reductions of hematocrit, but inadequate dilation at more severe reductions of hematocrit. The second objective of the present study was to test the hypothesis that cotransfusion of PVP with either Alb or polymeric Hb solutions results in increases in pial arteriolar diameter compared with the corresponding responses with either Alb or Hb transfusion alone. It was also determined whether the increase in diameter was sufficient for maintaining CBF and O 2 transport.
The influence of hematocrit on CO 2 reactivity has not been well studied. Increases in CBF during hypercapnia remain when red blood cells are nearly completely replaced by cell-free Hb at a hematocrit of ϳ2% (13, 30) . However, plasma viscosity can modulate the CBF response to hypercapnia (25) . Increases in arterial diameter after PVP infusion could limit vasodilatory reserve to physiological stimuli such as hypercapnia. Moreover, decreases in arteriolar diameter after Hb transfusion could limit the vasoconstrictor capacity to physiological stimuli such as hypocapnia. The third objective was to test the hypothesis that the vasoconstrictor response to hypocapnia and the vasodilatory response to hypercapnia remained intact after transfusion of either Alb or Hb solutions with or without concurrent PVP infusion despite changes in baseline diameter and blood O 2 -carrying capacity.
METHODS
Hemoglobin polymer synthesis. The Hb-based O2 carrier was obtained first by reacting bovine Hb with bis(3,5-dibromosalicyl)adipate to form intramolecular cross-links. The cross-linked tetramers were then treated with 1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide to achieve polymerization of the Hb molecules with an estimated nominal molecular mass of ϳ20 MDa as previously described (14) . The solution was subjected to diafiltration at 300 kDa to separate large-molecular weight polymerized Hb from the remaining tetramers and small polymers. The purified large polymers were transferred into lactated Ringer solution by dialysis, detoxificated with Detoxigel (Pierce), irradiated to avoid any endotoxin contamination, and stored at Ϫ70°C. The PO2 at 50% oxyhemoglobin saturation (P50) was near 4 mmHg at 37°C with essentially no cooperativity or Bohr effect. The Hb concentration in the final solution was between 11 and 12 g/dl with a colloid osmotic pressure of ϳ10 mmHg (cat plasma ϳ15 mmHg).
Surgical procedures. All experiments were approved by the institutional animal care and use committee. Mixed-breed male cats weighing 2.4-3.1 kg were anesthetized with halothane (2-3%) for oral intubation and insertion of arterial and venous catheters. Two catheters were placed into femoral veins and advanced into the inferior vena cava for infusion of drugs and transfusion of fluids during the blood exchange. One femoral arterial catheter was used for the continuous monitoring of arterial blood pressure, and a second arterial catheter was used for withdrawal of blood during exchange transfusion and microsphere blood flow measurements. After a left thoracotomy, a catheter was inserted into the left atrium for the injection of radiolabeled microspheres. After these surgical procedures, halothane was discontinued, and anesthesia was maintained with pentobarbital and fentanyl. The cat was turned prone, and its head was positioned in a stereotaxic frame ϳ3 cm above the heart. After a 1-cm cylinder of bone was removed over the right parietal cortex, a plastic ring was placed around the hole and filled with artificial cerebrospinal fluid (1) . In this chamber the dura was cut, and the pial vessels were exposed. A thermistor was integrated in this chamber. Chamber temperature was maintained at 38 Ϯ 0.5°C with a heating lamp while body temperature was maintained with a warmed water blanket. The chamber was sealed with a glass coverslip. Diameter of pial arterioles was measured with a microscope fitted with a video camera. The percent changes in diameter were analyzed separately for arterioles with baseline diameters Ͻ50, 50-100, and Ͼ100 m. When multiple arterioles of each size category were present, the percent responses were averaged so that a single value was used for each cat in the statistical analysis.
Arterial blood pressure was continuously monitored. Arterial pH, Pa CO 2 , and PaO 2 were measured with a self-calibrating electrode system (model 246, Chiron Diagnostics). Total Hb and CaO 2 were measured with a hemoximeter adjusted for cat blood (model OSM 3, Radiometer). Values for plasma Hb were reported as an equivalent concentration of Hb tetramers. The algorithm used for cat blood by the hemoximeter was found to underestimate the ZL-HbBv concentration by 15% compared with samples measured spectrophotometrically with an extinction coefficient of 0.837 cm 2 /mg at 540 nm after treatment of the samples with carbon monoxide and sodium dithionite. Accordingly, corrections of whole blood Hb values were made based on the fraction of Hb in the plasma compartment. Because less than one-third of total Hb in the blood sample was ZL-HbBv, the corrected values were within 5% of the values measured with the hemoximeter. Plasma viscosity was measured gravimetrically with an Ostwald viscometer. Regional CBF was measured with radiolabeled microspheres (15.5 Ϯ 0.5 m diameter, New England Nuclear) by the reference withdrawal method (5). Six radioactive isotopes ( 57 Co, 114m In, 113 Sn, 103 Ru, 95 Nb, and 46 Sc) were injected in random sequence into each animal. Approximately 1.5 ϫ 10 6 microspheres were injected into the left atrium over a 20-s period, followed by a 5-ml saline flush. Reference blood samples were withdrawn from the aorta at 1.94 ml/min beginning 30 s before the injection and continuing for 90 s after the saline flush. Tissue and blood samples were analyzed in an autogamma scintillation spectrometer (Minaxi model 5530, Packard Instruments). Blood flow was calculated as the product of the withdrawal rate (1.94 ml/ min) times the counts in the tissue (corrected for the isotope overlap) divided by the counts in the arterial reference sample. Cerebrovascular resistance was calculated as mean arterial blood pressure divided by CBF. Cerebral O 2 transport was calculated as the product of CBF and Ca O 2 .
Experimental protocol. After 45 min from the end of the surgical preparation, baseline value measurements of arterial blood gas values, arterial pressure, blood flow, and pial arteriolar diameter were made. The cats were assigned to one of the following five groups: 1) control group, in which no exchange transfusion was performed (n ϭ 10); 2) exchange transfusion with 5% human Alb solution (Alb group; n ϭ 10); 3) exchange transfusion with the Hb solution (Hb group n ϭ 9); 4) exchange transfusion with 5% human Alb solution and 20% PVP solution (1.1 MDa) in a dose of 1.1 mg/kg to induce an increase in plasma viscosity (AlbϩPVP group; n ϭ 8); and 5) exchange transfusion with the Hb solution and 20% PVP (1.1 mg/kg) (HbϩPVP group; n ϭ 6). Transfusion of the PVP solution was alternated intermittently with transfusion of the Alb or Hb solution. The exchange transfusion was done at a rate of 1.9 ml/min until the hematocrit was reduced to ϳ18% (ϳ30 min). Additional amounts of either Alb or ZLHbBv solutions were infused in the respective groups during the experiment to replace blood volume during sampling and to keep hematocrit constant.
Sets of measurements were obtained 1 and 2 h after the end of the transfusion. Hypocapnia (PaCO 2 ϳ20 mmHg) was then induced by increasing the ventilatory rate. Measurements were taken at 10 min of hyperventilation and 20 min after the return to normocapnia. Hypercapnia (Pa CO 2 ϳ70 mmHg) was then produced by adding CO2 to the inspired gas, and measurements were repeated at 10 min of hypercapnia.
Statistical evaluation. Values among the five groups at each time point were compared by one-way ANOVA and the Newman-Keuls multiple range test at P Ͻ 0.05. Comparisons of CBF and O 2 transport at 1 and 2 h after transfusion were made with baseline values within groups by paired t-tests with the Bonferroni correction. Data are presented as means Ϯ SE.
RESULTS
Effect of exchange transfusion. Exchange transfusion with Alb, Alb ϩ PVP, polymeric Hb, and Hb ϩ PVP decreased hematocrit to 18-19% ( Table 1 ). The total Hb concentration (red blood cells ϩ plasma) and Ca O 2 were decreased in the Alb, Alb ϩ PVP, and Hb ϩ PVP groups compared with the control group. The total equivalent Hb concentration was higher in the Hb and 
Hb ϩ PVP groups than in the Alb and Alb ϩ PVP groups. In the Hb group, Ca O 2 was also greater than in the Alb group but less than in the control group. Table 1) . Coinfusion of PVP increased plasma viscosity two-to threefold compared with the corresponding values in the Alb and Hb groups ( Table 2 ). Mean arterial blood pressure was not significantly changed at 1 or 2 h after transfusion in any group (Fig. 1) . Arterial pressure in the transfused groups did not differ significantly from values in the control group at any time point during the experiment.
Hemodilution with Alb caused an increase of mean CBF that maintained cerebral O 2 transport (Fig. 2) . Coinfusion of PVP with Alb also resulted in an increase in CBF from baseline, but CBF was not significantly different from CBF in the control group. Although CBF in the Alb ϩ PVP group was less than CBF in the Alb group, neither the percent increase in CBF nor the change in O 2 
Cerebrovascular resistance (CVR) decreased after exchange transfusion with Alb or Alb ϩ PVP, and the percent change was significantly different from the time control group (Fig. 3) . Hemodilution with Alb or with Alb ϩ PVP produced a similar degree of pial arteriolar dilation. Transfusion of Hb generated pial Fig. 1 . Mean arterial blood pressure at baseline, 1 and 2 h after exchange transfusion, during hypocapnia (Hypocap), normocapnic recovery, and hypercapnia (Hypercap) in a time-control group and groups transfused with albumin (Alb), Alb plus polyvinylpyrrolidone (Alb ϩ PVP), zero-link hemoglobin (Hb) polymer, and Hb plus PVP (Hb ϩ PVP) solutions. There were no differences from the control group. arteriolar constriction at 1 h in all size vessels without a significant change in CVR. By 2 h, the constrictor response was attenuated. However, coinfusion of PVP with Hb reversed the early vasoconstrictive effect and resulted in sustained pial vasodilation of all size arterioles. The percent change in diameter in the Hb ϩ PVP group differed significantly from that in the Hb group and, in the case of the smallest and largest arterioles, from the Alb ϩ PVP group. In contrast, the percent change in CVR was not different from values in the control or Hb group.
Effect of hemodilution on the CO 2 response of pial arterioles. The level of Pa CO 2 achieved during hypocapnia and hypercapnia was similar among groups (Table  1) . Hypocapnia caused a CBF reduction in the control and Alb groups but no significant change in the other groups (Fig. 4A) . The percent decreases in CBF in the Alb ϩ PVP, Hb, and Hb ϩ PVP groups were significantly smaller than that in the control group. With induction of hypercapnia, the percent increase in CBF was attenuated in the Alb ϩ PVP, Hb, and Hb ϩ PVP groups compared with both the control and Alb groups (Fig. 4B) .
The percent increase in CVR during hypocapnia was significantly attenuated in the Alb group, and no significant change in CVR occurred in the Alb ϩ PVP, Hb, and Hb ϩ PVP groups (Fig. 5) . Compared with the vasoconstrictor response of pial arterioles in the control group, the hypocapnia-induced vasoconstrictor response was impaired in all of the other groups (Fig. 5) . The addition of PVP to Alb or Hb did not restore the hypocapnic response.
The percent decrease in CVR during hypercapnia was attenuated in the Hb ϩ PVP group compared with the control group. The hypercapnic dilation of pial arterioles was intact in all size vessels in the Alb and Hb groups. In large vessels, however, the addition of PVP to Alb or Hb significantly attenuated the vasodilator response to hypercapnia compared with the control group. Large vessel dilation in the Hb ϩ PVP group also was less than that in the Hb group. In small arterioles, the group effect on hypercapnic dilation was less consistent (P ϭ 0.1).
DISCUSSION
The major findings of this study were that 1) differences in the cerebrovascular response to exchange transfusion of an Alb solution versus the Hb polymer persist over a 2-h period at similar levels of arterial pressure, 2) the compensatory vasodilation to an im- posed increase in plasma viscosity is more prominent in the presence of the plasma-based O 2 carrier than at an equivalent hematocrit achieved with Alb transfusion, 3) decreasing hematocrit with or without a plasma-based O 2 carrier does not interfere with hypercapnic dilation of pial arterioles unless plasma viscosity is increased, and 4) vasoconstriction of pial arterioles to hypocapnia is impaired at a reduced hematocrit independent of changes in Ca O 2 and plasma viscosity.
Hemodilution results in a decrease in CVR that can be accompanied by either decreases (6, 16, 17) , no change (10), or increases (1) in arterial diameter. Active changes in arteriolar diameter have been referred to as viscosity autoregulation, analogous to pressureinduced autoregulation (18) . In the case of viscosity autoregulation, changes in vascular diameter will be affected by changes in endothelial wall shear stress and by oxygenation. Changes in oxygenation, in turn, will be influenced by the balance of decreased blood viscosity promoting blood flow versus the decrease in O 2 -carrying capacity. Thus the variable changes in arteriolar diameter reported in the literature during hemodilution may be influenced by the balance of several factors including baseline values of hematocrit, viscosity, O 2 -carrying capacity, vascular diameter, and oxidative metabolism, as well as the degree of hemodilution and its associated effects on these parameters. In the present model using anesthetized cats in which arterial hematocrit is reduced from ϳ32% to 18-19%, we observed dilation of pial arterioles both in the current study as well as in a previous report (1) . This vasodilation was associated with an increase in CBF that was sufficient to maintain cerebral O 2 transport. Maintenance of cerebral O 2 transport during anemia has been described in several studies (2, 6, 11), although some investigators have reported a moderate decrease in bulk oxygen transport (4, 24) . Therefore, we have postulated that active changes in vascular diameter during anemia represent an oxygen-dependent regulatory process.
Our data with cell-free Hb are consistent with this oxygen-dependent hypothesis. Exchange transfusion with cell-free Hb or Alb to a hematocrit of 18% in the cat decreases whole blood viscosity equivalently by ϳ25% (27) , yet changes in arteriolar diameter are directionally different (1) . The decrease in arteriolar diameter observed in the present study with a large-MW polymer of ZL-HbBV is similar in magnitude to that previously reported with the lower MW crosslinked tetrameric Hb at similar plasma concentrations of heme (1) . Because exchange transfusion of the ZLHbBv polymer did not increase arterial blood pressure, the decrease in arteriolar diameter is not primarily due to an increase in transmural pressure. Furthermore, the constriction is unlikely to be solely due to scavenging of NO by cell-free Hb because 1) NO synthase inhibition causes a decrease in cerebral O 2 transport (15), whereas we observed no change in cerebral O 2 transport after Hb transfusion; and 2) endothelialdependent dilation of pial arterioles to acetylcholine and ADP is not attenuated by the presence of cell-free Hb in the plasma (1) . Therefore, the maintenance of cerebral O 2 transport at equivalent levels after Alb transfusion and ZL-HbBv transfusion argues that changes in arteriolar diameter compensate for imposed changes in viscosity in a manner that maintains bulk O 2 transport to the microcirculation. This concept is also consistent with our previous observations showing that decreasing Pa O 2 after exchange transfusion with Alb or cross-linked Hb tetramers results in indistin- guishable levels of CBF at equivalent levels of Ca O 2 and consequently results in constant O 2 transport (28).
Constriction was observed in all size pial arterioles 1 h after transfusion of ZL-HbBv. This pattern is somewhat different from that obtained during arterial hypertension, where the percent constriction is greater in larger arteries (12) . This constrictor response was blunted by 2 h after transfusion. This attenuation was not attributable to changes in arterial blood gas values or by a decrease in plasma Hb concentration. Thus there appears to be some adaptation over time to the postulated O 2 -dependent constrictor response. Nevertheless, the change in diameter after ZL-HbBv transfusion remained significantly different from that seen 2 h after Alb transfusion.
Transfusion of PVP to increase plasma viscosity has been tested in conscious rats at different levels of hematocrit (21) . Results indicated that cerebral O 2 transport could be maintained when PVP was infused over a hematocrit range of 19-30% but that O 2 transport declined when PVP was transfused at a hematocrit of 15%. These results imply that increasing plasma viscosity causes additional cerebral vasodilation to help maintain O 2 transport during moderate anemia but that vasodilatory reserve becomes limited during severe anemia, when tissue hypoxia is presumed to become more prominent (2). Thus we anticipated that the increase in pial arteriolar diameter in the Alb ϩ PVP group would be greater than in the Alb group to compensate for the twofold increase in plasma viscosity. However, the dilation was similar in magnitude in all size arterioles in the Alb and Alb ϩ PVP groups. One explanation for a similar percent increase in CBF in the Alb and Alb ϩ PVP groups despite a difference in plasma viscosity is that small intraparenchymal arterioles dilated to a greater extent in the Alb ϩ PVP group. Another issue is the impact of increasing plasma viscosity on whole blood viscosity. We did not measure whole blood viscosity in this experiment. It is possible that the increase in plasma viscosity to 2.4 cP in the Alb ϩ PVP group did not have a large enough effect on whole blood viscosity to cause additional pial arteriolar dilation. The lack of additional dilation was not due to an inability of the blood vessels to further dilate, because additional dilation was observed during hypercapnia, albeit at a reduced magnitude. Increasing plasma viscosity with high-molecular weight dextran in anesthetized rats reduced CBF at a hematocrit of 15% (25) . Furthermore, doubling plasma viscosity with dextran infusion, which decreased hematocrit from ϳ43 to 34%, failed to increase CBF in anesthetized dogs (3), thereby implying that cerebral O 2 transport decreased. A similar finding was observed in humans with proteinemia (9) . Therefore, the lack of additional vasodilation in the Alb ϩ PVP group in the present study is probably not specific for the use of PVP to increase plasma viscosity.
In contrast to the lack of additional vasodilation with coinfusion of PVP and Alb, coinfusion of PVP with the ZL-HbBv polymer resulted in marked dilation of pial arterioles. This vasodilation prevented a decrease in CBF in the face of a twofold increase in plasma viscosity. This result is consistent with the argument that the decrease in vascular diameter seen with ZL-HbBv transfusion alone was a consequence of decreased blood viscosity because the response can be converted to a vasodilatory response when plasma viscosity is increased. Thus the presence of a cell-free Hb polymer, per se, does not interfere with viscosity autoregulation. These results are in agreement with those of Waschke et al. (31) , who reported no decrement in CBF when PVP was coinfused with tetrameric Hb at a hematocrit of only 2-3%. Interestingly, increasing plasma viscosity with high-MW dextran reduced CBF under conditions of hypoxic hypoxia but not during normoxia (25) . One explanation for these observations is that tissue hypoxia interferes with viscosity autoregulation. Our finding of vasodilation with coinfusion of PVP and ZL-HbBv, which exceeded the vasodilation with coinfusion of PVP and Alb, implies that viscosity autoregulation depends on enhanced oxygenation provided by cell-free Hb.
Despite the increase in arteriolar diameter after coinfusion of PVP and ZL-HbBv, cerebral O 2 transport decreased. One limitation of this experiment is that coinfusion of PVP resulted in a lower Hb concentration in the plasma at equivalent hematocrit. To achieve a plasma Hb concentration comparable with the group transfused with ZL-HbBv alone would have required mixing PVP with a concentration of ZL-HbBv two-to threefold greater than the 12% solution transfused in the ZL-HbBv group. This was not feasible. Hence, we elected to keep the reduction in hematocrit and the amount of PVP infused comparable with the Alb ϩ PVP group and let the plasma Hb concentration be less than in the ZL-HbBv group. Consequently, Ca O 2 with PVP plus ZL-HbBv was less than with ZL-HbBv alone. Thus we cannot exclude that part of the vasodilation response was attributable to a decrease in Ca O 2 . However, it should be borne in mind that delivery of O 2 to the tissue by cell-free Hb is related not only to the O 2 unloaded solely from the cell-free Hb but also potentially by facilitated unloading of O 2 from red blood cell-based Hb. One component of the resistance to O 2 delivery into the tissue is attributed to the low solubility of O 2 in the plasma between red blood cells and the endothelial wall. In vitro, cell-free Hb delivers O 2 more effectively than an equivalent amount of red blood cell Hb (19, 20) . The presence of the Hb polymer in the plasma increases the effective O 2 solubility and may facilitate the transport of O 2 from the red blood cell to the vascular wall. This mechanism may contribute to the postulated increased tissue oxygenation despite the high O 2 affinity of this Hb polymer (P 50 ϳ4 mmHg).
Cerebrovascular reactivity to hypercapnia has not been well studied under anemic conditions. The present results indicate that pial arterial diameter dilation during hypercapnia was not impaired after hemodilution with the Alb solution or by the presence of the cell-free Hb polymer. However, the percent increase in CBF was attenuated by the Hb polymer. This result suggests that vasodilation in intraparenchymal vessels was reduced in the presence of the polymer possibly as a result of increased tone secondary to enhanced perivascular PO 2 by the plasma-based O 2 carrier. With both Alb ϩ PVP transfusion and Hb ϩ PVP transfusion, the CBF and large pial arterial responses to hypercapnia were attenuated. The CBF response to hypercapnia has also been reported to be attenuated by transfusion of high-molecular weight dextran (25) and by coinfusion of PVP with crosslinked tetrameric Hb (13) . The increase in normocapnic baseline diameter in both PVP groups may account for the limited hypercapnic vasodilation. However, normocapnic baseline diameter in the Alb ϩ PVP group was similar to that in the Alb group, yet the vasodilatory response to hypercapnia was greater in the Alb group. Thus there may be an effect of plasma viscosity on hypercapnic dilation independent of baseline diameter.
In the case of hypocapnia, both the increase in CVR and the decrease in diameter of all size pial arterioles were markedly reduced in all four transfused groups. This unexpected result indicates that the loss of hypocapnic vasoconstriction may be related to the low hematocrit, per se, rather than to an effect of viscosity, oxygenation, or baseline diameter. In particular, the lack of hypocapnic constriction with ZL-HbBv transfusion is probably not attributable to changes in baseline diameter or wall shear stress because increasing these parameters with coinfusion of PVP did not restore hypocapnic constriction. In the case of transfusion of Alb alone, hypocapnia still produced a decrease in CBF despite the loss of pial arteriolar constriction. These results imply that hypocapnic vasoconstriction was not completely lost in intraparenchymal arterioles.
In summary, increasing arterial O 2 -carrying capacity at a reduced hematocrit with the ZL-HbBv polymer resulted in vasoconstriction that counteracted the reduced blood viscosity such that there was little net change in overall CVR. In contrast, increasing plasma viscosity prevented this vasoconstrictor response. These results support the concept that active changes in cerebrovascular diameter to imposed changes in blood viscosity represent an O 2 -dependent process that attempts to maintain cerebral O 2 transport.
